Immunofluorescence-based diagnostic platform for detection and identification of specific antigens or antibodies in clinical samples. Provides fluorescence-based results for rapid point-of-care and laboratory testing.
Manufactured by
Guangzhou, Guangdong, China
Guangzhou Wondfo Biotech Co., Ltd. founded in 1992 and headquartered in Guangzhou science city. Wondfo focuses on the R D, manufacturing, sales and service of IVD industry , providing professional rapid diagnosis and chronic disease management solutions. Wondfo has 9 technology platforms . Our rapid diagnostic devices and reagents span a wide spectrum, including cardiovascular diseases, diabetes, renal functions, respiratory issues, fertility, DOA, infections, tumors, etc . We provide services to over 150 countries and regions . In 2015, Wondfo was listed on the Shenzhen Stock Exchange, becoming the first public company in POCT in China .
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
ReLIA Bioengineering(Jiangsu), Inc
China · 1 relevant product
Shenzhen YHLO Biotech Co., Ltd.
China · 4 relevant products
Xenta Biomedical Science Co.,Ltd
China · 2 relevant products
Beijing Zhongjian Antai Diagnostic Co., Ltd.
China · 1 relevant product
Vitrosens Biyoteknoloji Anonim Sirketi
Türkiye · 1 relevant product
B&C Biological
China · 1 relevant product
Shenzhen Kingfocus Biomedical Engineering Co., Ltd.
China · 1 relevant product
S&T BioMed CO., LTD.
Taiwan · 1 relevant product
Shenzhen Microprofit Biotech Co., Ltd
China · 3 relevant products
Shanghai Beion Medical Technology Co.,LTD.
China · 1 relevant product
24 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 45 closest product alternatives
ReLIA Bioengineering(Jiangsu), Inc · China
A diagnostic platform for point-of-care testing (POCT) that uses immunofluorescence technology for rapid and accurate detection. The platform features precise temperature control, multiple connectivity options, and automatic sample identification to enable quick diagnostic testing.
Shenzhen YHLO Biotech Co., Ltd. · China
An indirect immunofluorescence technology platform for serological testing and antibody detection. The system is utilized for diagnosis of autoimmune and infectious diseases through fluorescence-based immunoassay methodology.
Xenta Biomedical Science Co.,Ltd · China
An immunolayer chromatography technology platform utilizing fluorescence detection for rapid diagnostic testing. Provides high sensitivity across multiple analyte categories including thyroid markers.
Beijing Zhongjian Antai Diagnostic Co., Ltd. · China
Fluorescence quantitative immunoassay platform for in vitro diagnostic testing of infectious diseases, respiratory pathogens, and gastrointestinal markers. The system enables quantitative analysis using fluorescence immunoassay technology with Class II medical device certification across multiple regulatory markets. Supports high-throughput diagnostic workflows in clinical laboratories and reference testing facilities.
Vitrosens Biyoteknoloji Anonim Sirketi · Türkiye
Immunofluorescence-based diagnostic platform for infectious disease detection providing accurate and fast results.
B&C Biological · China
A fluorescence-based immunoassay platform from the POCT series designed for rapid diagnostic testing. The SF-100 platform enables high-sensitivity and high-precision immunofluorescence detection for various clinical analytes and sample types.
Shenzhen YHLO Biotech Co., Ltd. · China
An immunoblot technology platform for protein detection and analysis in clinical diagnostics. The system utilizes antibody-based detection methods for identification of specific antigens in patient samples.
Shenzhen Kingfocus Biomedical Engineering Co., Ltd. · China
Quantum dot fluorescence-based platform for in vitro diagnostic applications. Supports development of various immunological assays with enhanced optical properties and batch consistency.
Shenzhen YHLO Biotech Co., Ltd. · China
A comprehensive technology platform utilizing chemiluminescence immunoassay methodology for in vitro diagnostic testing. The platform enables sensitive and specific detection of various clinical markers including reproductive, autoimmune, infectious disease, and metabolic parameters.
S&T BioMed CO., LTD. · Taiwan
Automated immunoassay system utilizing electrochemical detection methods for biomarker quantification. Suitable for high-throughput clinical laboratory applications.
Shenzhen Microprofit Biotech Co., Ltd · China
CE-marked fluorescence immunoassay (FIA) analyzer for quantitative point-of-care testing. The MF-T1000 platform delivers rapid diagnostic results with 92.9%+ sensitivity, supporting respiratory combo tests (4-in-1/9-in-1 configurations) for clinical laboratories and healthcare facilities.
Shenzhen Microprofit Biotech Co., Ltd · China
Point-of-care immunofluorescence test platform for rapid pathogen detection. Utilizes fluorescence technology for sensitive and specific clinical diagnostics.
33 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products